MEDIA RELEASE
FOR IMMEDIATE USE
Ethyloestrenol Update
Greyhounds Australasia (GA) at its 6 March 2008 meeting discussed issues surrounding the availability of Ethyloestrenol in veterinary products.
In that regard, it was confirmed that Intervet, the current manufacturer of Nandoral tablets (i.e. a brand of veterinary product which contains Ethyloestrenol) will cease supplying Nandoral tablets later in 2008.
However, GA is aware of another pharmaceutical manufacturer which has begun the necessary steps to register an alternative to the Nandoral Ethyloestrenol tablet. Furthermore, it was also established that there will be sufficient supply of Ethyloestrenol in other brands of veterinary products during this time.
Based on this information, it was resolved by GA Members to recommend to Member jurisdictions that the implementation date of the change to the definition of drugs allowing for Ethyloestrenol in bitches only would remain effective 1 July 2008 on the basis that Ethyloestrenol is prescribed by a registered veterinarian.
If participants have any questions in relation to this matter, please contact your respective Controlling Body or GA.
CRAIG TABERNER
GREYHOUNDS AUSTRALASIA
Ph: (03) 9548 3500
14 March 2008
Please note:
GA reminds participants that Nandoral tablets and Nitrotain paste are brands of veterinary products that contain Ethyloestrenol. However neither the GA Board nor the various State and Territory controlling bodies have the legal right to endorse the prescription of these or other Ethyloestrenol products - that is a legal right of veterinarians.
